dystrophy is a general term for progressive degeneration or dysfunction of a tissue or organ arising from defective nourishment, faulty metabolism, or a genetically defective structural protein, rather than from disuse or normal aging. It differs from atrophy, which is the wasting or shrinkage of tissue that formed and developed normally before losing mass or function — dystrophy implies the tissue’s underlying nutrition or structural maintenance was disordered from the outset, even if onset is delayed into adulthood. The mechanism is typically genetic (e.g., mutations affecting structural proteins such as dystrophin in Duchenne muscular dystrophy, or endothelial cell dysfunction in Fuchs’ corneal dystrophy) or metabolic/nutritional. Dystrophy is almost always pathological, though the term “trophic” (physiological nourishment/growth signaling) describes the normal process it disrupts. Clinically relevant subtypes commonly encountered in coding include muscular dystrophy (G71.0-), hereditary corneal dystrophy (H18.5-), hereditary retinal dystrophy (H35.5-), and nail dystrophy (L60.3). dystrophy is often confused with atrophy (loss of previously normal tissue mass) and with hypertrophy (excessive tissue growth) — the key distinguishing feature of dystrophy is disordered, defective tissue formation or maintenance, not simply a change in tissue size.
The word entered English in the 1830s as dystrophy (noun), borrowed from French dystrophie, from Greek dys- + trophē — literally “bad nourishment.” The root troph- (“nourishment, growth”) connects dystrophy to the entire -trophy root family: atrophy (a- “without” + troph- → “without nourishment,” tissue wasting), hypertrophy (hyper- “excessive” + troph- → excessive growth from enlarged cells), and trophic (adjective, “relating to nutrition or growth signaling”). The prefix dys- is highly productive in medical terminology: dysphagia, dysplasia, dyspnea, dyskinesia.
🔀 ALIASES / ALTERNATE TERMS
Dystrophic(adjective form — e.g., “dystrophic cornea,” “dystrophic nails,” “dystrophic calcification”)
Corneal dystrophy(hereditary, typically bilateral corneal disorder; H18.5- family — high-yield for ophthalmology coding)
Myotonic dystrophy(DM1/DM2 — multisystem disorder with myotonia and muscle wasting; G71.11)
Complex regional pain syndrome (formerly reflex sympathetic dystrophy/RSD)(now coded as CRPS I; G90.5-, laterality and limb-specific)
Nail dystrophy(structural nail plate abnormality; L60.3)
Adiposogenital dystrophy (Fröhlich syndrome)(hypothalamic-pituitary disorder with obesity and hypogonadism; E23.6)
🔗 RELATED TERMS
Atrophy — closely confused term; unlike dystrophy, atrophy is shrinkage of previously normal tissue from cell loss or reduced cell size, not defective formation.
Hypertrophy — shares the troph- root; excessive tissue growth from enlarged (not increased number of) cells, the structural opposite of wasting-type dystrophies.
Trophic — adjective describing nerve, hormonal, or vascular inputs that sustain normal tissue nourishment and growth; disruption of trophic signaling underlies many dystrophic processes (e.g., “trophic ulcers”).
Apoptosis — programmed cell death; a cellular mechanism implicated in the progressive tissue loss seen in genetic dystrophies such as muscular dystrophy and retinal dystrophy.
G71.01 — Duchenne or Becker muscular dystrophy, the disease entity most classically named for this process; X-linked, dystrophin gene defect.
H18.51 — Fuchs’ endothelial corneal dystrophy, the most common corneal dystrophy requiring surgical management in adults.
H35.51 — Retinitis pigmentosa, the prototypical hereditary retinal dystrophy.
Electromyography (EMG) — primary diagnostic tool for evaluating suspected muscular dystrophy, distinguishing myopathic from neurogenic patterns.
Specular microscopy — key diagnostic imaging modality for corneal endothelial dystrophies, quantifying endothelial cell density and morphology.
CODING CORNER
🏥 ICD-10-CM CODES
Muscular Dystrophy (G71.0- — Type Specificity Required)
Needle electromyography; two extremities with or without related paraspinal areas
⚠️ Coding Note:Corneal dystrophy codes (H18.5-) do not carry a laterality character despite being typically bilateral — resist the urge to append a 7th character. By contrast, CRPS/RSD codes (G90.5-) require both limb and laterality specificity; unspecified-limb codes (G90.519, G90.529) should trigger a query rather than default use. For muscular dystrophy, sequence the specific dystrophy code (G71.01, etc.) as principal when it is the reason for admission or focus of inpatient care (e.g., respiratory failure secondary to Duchenne MD); use the MD code as a secondary/CC-capturing diagnosis when the patient is admitted for an unrelated condition but the dystrophy affects management (mobility, ventilator dependency, aspiration risk). A common undercoding trap on inpatient profee claims: documentation reading “muscle weakness” or “family history of muscular dystrophy” without a confirmed subtype should prompt a CDI query for Duchenne vs. Becker vs. facioscapulohumeral specificity (G71.01/.02 vs. unspecified G71.00), since payer prior-authorization for genetic testing (e.g., dystrophin gene panels) and DMD-targeted therapies often hinges on subtype documentation. For endothelial keratoplasty (65756), confirm laterality via modifier -RT/-LT (or -50 if staged/bilateral per payer policy) since Fuchs’ dystrophy is frequently bilateral but surgeries are typically staged.